AzTrials
AzTrials

Type1 Diabetes MellitusNCT04725799

Additional Signals for Exercise, Stress and Sleep and Prediction of Glucose Levels for AP Systems

An observational study of Type1 Diabetes Mellitus, run by University of Illinois Chicago at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The objective of this research is to determine the most informative variables for detecting exercise, acute stress and sleep, identify select sensors that report these variables, and develop the algorithms to detect the occurrence of exercise, stress and sleep, to discriminate them and to determine their… Read more about this study

Who is it for?
Ages 18 to 60 years
Conditions the study is for
Type1 Diabetes Mellitus
How many people
23 participants
Where
1 siteUnited States
Study dates
24 May 2018to 13 Jul 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Study population: Men and Women with Type 1 Diabetes

Who may be able to join

  • Men and Women with T1DM
  • 18-60 years of age
  • Insulin pump user

Who cannot join

  • Metabolic instability as evidenced by hospitalizations for diabetes or other diabetes-related complications (e.g., diabetic ketoacidosis and hypoglycemic seizures) within the preceding three months;
  • Severe macrovascular disease, as evidenced by severe peripheral artery disease; history of myocardial infarction, heart failure, thromboembolic disease, or unstable angina; uncontrolled hypertension; abnormal resting EKG;
  • Maximal exercise stress test with significant brady/tachy arrhythmia, ectopic beats, bundle branch block, or signs of acute ischemia;
  • Severe microvascular disease as evidenced by history of vision-threatening proliferative or non-proliferative retinal disease; kidney disease;
  • Any uncontrolled non-musculoskeletal condition that would limit the subject's ability to participate in the exercise program (e.g., chronic obstructive airways disease);
  • Musculoskeletal conditions such as neurological or orthopedic conditions affecting lower limb strength and mobility (e.g., stroke; insensitive foot);
  • Pregnancy;
  • Documented medical condition or physical impairment that is judged by the health care practitioner to contraindicate exercise.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Illinois at Chicago

    Chicago, Illinois, 60612

Other trials in United States

About this study

Official title: Additional Signals for Detection of Exercise, Stress and Sleep Effects and Prediction of Glucose Levels for Next Generation AP Systems

The objective of this research is to determine the most informative variables for detecting exercise, acute stress and sleep, identify select sensors that report these variables, and develop the algorithms to detect the occurrence of exercise, stress and sleep, to discriminate them and to determine their characteristics. Research is needed to identify which wearable devices report the most informative and predictive variables of exercise, acute stress and sleep with desired precision and accuracy, determine the best location to wear them for collecting reliable and informative data, and to distill accurate knowledge from data reported by wearable sensors. Data and their interpretation should be informative for various types of physical activities, stages of sleep, and types and intensities of acute stress, and concurrent occurrence of these factors. The investigators will use several devices (chest band, wristband and skin patches) to collect data and evaluate their information content and contribution to improvement of glucose concentration prediction, best locations for collecting accurate and reliable information by conducting clinical and free-living experiments at-home to assess the contributions of the wearable device in improving the accuracy of glucose concentration prediction and the performance of the multivariable artificial pancreas.

Read the detailed description

The focus of the proposed work is to determine the most informative variables for meals, exercise, acute stress and sleep (MESS), identify select sensors that report these variables, and develop the algorithms to detect the occurrence of MESS, to discriminate them and to determine their characteristics. Research is needed to identify which wearable devices report the most informative and predictive variables of MESS with desired precision and accuracy, determine the best location to wear them for collecting reliable and informative data, and to distill accurate knowledge from data reported by wearable sensors. Data and their interpretation should be informative for various types of physical activities, stages of sleep, and types and intensities of acute stress, and concurrent occurrence of MESS factors.

In the first year of the research, the investigators will use several devices to collect data and evaluate their information content and contribution to improvement of serum glucose prediction, best locations for collecting accurate and reliable information, and their acceptance by users. In the second year of the project, we will select a single wearable device, conduct additional clinical and free-living experiments at-home to assess the contributions of the information from the wearable device selected in improving the accuracy of glucose prediction and the performance of the multivariable AP.

The objectives of the proposed research are to determine the most informative variables and sensor locations to capture reliable and accurate information that complement glucose concentration measurements (CGM) and to develop algorithms to determine the presence of exercise, stress or sleep at any given time for estimating glucose concentrations and making control decisions by a multivariable artificial pancreas system. The proposed research will be conducted by achieving the following specific aims:

To systematically perturb the MESS factors within standardized experiments in the laboratory and at home for analyzing their effects and interactions on glucose concentrations; to identify the most informative and reliable measurement approaches (i.e. types of wearable sensors and locations on body) for discriminating MESS factors; to develop quantitative relations that identify the type and features of specific MESS activities, to develop algorithms to detect the presence of specific MESS activities, identify them, and predict glucose concentrations with recursive models in real time (for future integration with adaptive AP control systems); and to evaluate the performance of the multivariable models with data from wearable devices and CGM in closed-loop control with AP during exploratory clinical experiments.

The study will take place over a period of 3-4 weeks for a total of 6 study visits. The subjects will be continuously monitored using CGM (DEXCOM [US G5 PLATINUM]); 3 activity of the following activity monitor(s); (Empatica E4, BiostampRC™, Equivital™ Life Monitor) and Actigraph throughout the night. In addition, the subjects will use a sleep monitor (Zmachine® Insight \& Insight+ Model DT-200 and Zephyr Bioharness) throughout the 3-week period. Subjects will come in for a study visit 3 times during the first week during which the investigators will measure the subjects' oxygen capacity and muscular strength during a peak exercise stress test (peak V02) and a test of maximal muscle strength (1-RM), respectively. The results of this testing will establish a baseline from which we can calculate the intensity of submaximal aerobic and resistance exercise bouts. The next 3 study visits will occur over the following 3-4 weeks. During this time the subjects will perform activities that produce physiological and psychological stress alone, in combination or proximal to each other. Women will have a urine pregnancy test before each day of data collection. In addition, the subjects will perform a number of physical activities at home that will be scheduled with the research assistant. The research assistant will telephone the subjects periodically and have the subjects perform stressful activities, such as mental challenges.

Keywords
Exercise, Meals, Sleep, Stress, Artificial Pancreas
Medical subject headings
Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT04725799
Study groupRoleWhat they receive
MESS with and without stressful stimuliThe subjects participate in meal, exercise, sleep activities alone or in combination with stressful stimuli.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Measurement of Glucose Concentration

    • Glucose concentration (mg/dl) will be measured by: Continuous Glucose Monitor (DEXCOM [US G5 PLATINUM/G6]

    Measured: 3.5 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jan 2021
  2. Study start24 May 2018
  3. Primary completion13 Jul 2021
  4. Study completion13 Jul 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
23 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04725799
Sponsor's protocol ID
2017-1016
Status last verified
Mar 2022
First submitted
30 May 2018
Last updated
1 Apr 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Turksoy K, Samadi S, Feng J, Littlejohn E, Quinn L, Cinar A. Meal Detection in Patients With Type 1 Diabetes: A New Module for the Multivariable Adaptive Artificial Pancreas Control System. IEEE J Biomed Health Inform. 2016 Jan;20(1):47-54. doi: 10.1109/JBHI.2015.2446413. Epub 2015 Jun 16.

    PubMed 26087510
  • Eren-Oruklu M, Cinar A, Rollins DK, Quinn L. Adaptive System Identification for Estimating Future Glucose Concentrations and Hypoglycemia Alarms. Automatica (Oxf). 2012 Aug;48(8):1892-1897. doi: 10.1016/j.automatica.2012.05.076. Epub 2012 Jun 22.

    PubMed 22865931
  • Turksoy K, Bayrak ES, Quinn L, Littlejohn E, Rollins D, Cinar A. Hypoglycemia Early Alarm Systems Based On Multivariable Models. Ind Eng Chem Res. 2013 Sep 4;52(35):12329-36. doi: 10.1021/ie3034015.

    PubMed 24187436
  • Bayrak ES, Turksoy K, Cinar A, Quinn L, Littlejohn E, Rollins D. Hypoglycemia early alarm systems based on recursive autoregressive partial least squares models. J Diabetes Sci Technol. 2013 Jan 1;7(1):206-14. doi: 10.1177/193229681300700126.

    PubMed 23439179
  • Turksoy K, Roy A, Cinar A. Real-Time Model-Based Fault Detection of Continuous Glucose Sensor Measurements. IEEE Trans Biomed Eng. 2017 Jul;64(7):1437-1445. doi: 10.1109/TBME.2016.2535412. Epub 2016 Feb 25.

    PubMed 26930674

Questions about this trial

What is this clinical trial studying?

An observational study of Type1 Diabetes Mellitus, run by University of Illinois Chicago at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Measurement of Glucose Concentration (time frame: 3.5 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04725799, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Apr 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in